Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Qinghai Spring Medicinal Resources Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-8.22 Million ≈ $-1.20 Million USD) by net assets (CN¥1.03 Billion ≈ $151.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)

Cash flow conversion efficiency of Qinghai Spring Medicinal Resources Technology Co Ltd from 1999 to 2025. This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Qinghai Spring Medicinal Resources Techn share price for real-time trading data and today's change.

Qinghai Spring Medicinal Resources Technology Co Ltd Cash Flow Conversion Ratio Explained

Qinghai Spring Medicinal Resources Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their cash flow conversion efficiency. Also see 600381 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Qtone Education Group Guangdong Ltd SHE:300359	-0.005x
Radiant Logistics Inc NYSE MKT:RLGT	0.011x
International CSRC Investment Holdings Co Ltd TW:2104	-0.017x
NL Industries Inc NYSE:NL	0.019x
Fossil Group Inc NASDAQ:FOSL	0.080x
North American Construction Group Ltd TO:NOA	0.063x
AVIT Ltd SHE:300264	-0.688x
Seoul Food KO:004410	-0.015x

Annual Cash Flow Conversion Efficiency for Qinghai Spring Medicinal Resources Technology Co Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Qinghai Spring Medicinal Resources Technology Co Ltd from 1999 to 2025. Review 600381 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥999.61 Million ≈ $146.27 Million	CN¥-26.41 Million ≈ $-3.86 Million	-0.026x	-133.81%
2024-12-31	CN¥1.04 Billion ≈ $151.64 Million	CN¥80.97 Million ≈ $11.85 Million	0.078x	+314.06%
2023-12-31	CN¥1.27 Billion ≈ $185.45 Million	CN¥23.92 Million ≈ $3.50 Million	0.019x	+190.91%
2022-12-31	CN¥1.53 Billion ≈ $224.32 Million	CN¥-31.82 Million ≈ $-4.66 Million	-0.021x	+40.89%
2021-12-31	CN¥1.82 Billion ≈ $266.39 Million	CN¥-63.93 Million ≈ $-9.36 Million	-0.035x	+6.78%
2020-12-31	CN¥2.07 Billion ≈ $302.77 Million	CN¥-77.95 Million ≈ $-11.41 Million	-0.038x	+61.92%
2019-12-31	CN¥2.39 Billion ≈ $349.53 Million	CN¥-236.30 Million ≈ $-34.58 Million	-0.099x	-28.13%
2018-12-31	CN¥2.38 Billion ≈ $348.68 Million	CN¥-183.97 Million ≈ $-26.92 Million	-0.077x	-287.09%
2017-12-31	CN¥2.32 Billion ≈ $339.48 Million	CN¥95.74 Million ≈ $14.01 Million	0.041x	-76.03%
2016-12-31	CN¥2.00 Billion ≈ $293.22 Million	CN¥344.99 Million ≈ $50.48 Million	0.172x	-63.62%
2015-12-31	CN¥1.76 Billion ≈ $257.31 Million	CN¥832.17 Million ≈ $121.77 Million	0.473x	+262.85%
2014-12-31	CN¥308.44 Million ≈ $45.13 Million	CN¥-89.64 Million ≈ $-13.12 Million	-0.291x	+48.24%
2013-12-31	CN¥50.03 Million ≈ $7.32 Million	CN¥-28.09 Million ≈ $-4.11 Million	-0.561x	-72.31%
2012-12-31	CN¥2.15 Billion ≈ $314.92 Million	CN¥-701.18 Million ≈ $-102.61 Million	-0.326x	-402.13%
2011-12-31	CN¥2.32 Billion ≈ $339.20 Million	CN¥249.98 Million ≈ $36.58 Million	0.108x	+117.52%
2010-12-31	CN¥-116.10 Million ≈ $-16.99 Million	CN¥71.47 Million ≈ $10.46 Million	-0.616x	-180.00%
2009-12-31	CN¥-178.12 Million ≈ $-26.06 Million	CN¥39.16 Million ≈ $5.73 Million	-0.220x	-143.65%
2008-12-31	CN¥-230.81 Million ≈ $-33.78 Million	CN¥20.83 Million ≈ $3.05 Million	-0.090x	-367.44%
2007-12-31	CN¥-362.40 Million ≈ $-53.03 Million	CN¥7.00 Million ≈ $1.02 Million	-0.019x	+61.55%
2006-12-31	CN¥-429.60 Million ≈ $-62.86 Million	CN¥21.57 Million ≈ $3.16 Million	-0.050x	-110.15%
2005-12-31	CN¥327.77 Million ≈ $47.96 Million	CN¥162.12 Million ≈ $23.72 Million	0.495x	+616.00%
2004-12-31	CN¥489.71 Million ≈ $71.66 Million	CN¥33.83 Million ≈ $4.95 Million	0.069x	+1796.70%
2003-12-31	CN¥391.64 Million ≈ $57.31 Million	CN¥1.43 Million ≈ $208.72K	0.004x	-91.75%
2002-12-31	CN¥351.79 Million ≈ $51.48 Million	CN¥15.54 Million ≈ $2.27 Million	0.044x	+238.60%
2001-12-31	CN¥333.98 Million ≈ $48.87 Million	CN¥-10.64 Million ≈ $-1.56 Million	-0.032x	-183.07%
2000-12-31	CN¥117.80 Million ≈ $17.24 Million	CN¥4.52 Million ≈ $661.33K	0.038x	-93.81%
1999-12-31	CN¥113.38 Million ≈ $16.59 Million	CN¥70.28 Million ≈ $10.28 Million	0.620x	--

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic

Market Cap

$329.88 Million

CN¥2.25 Billion CNY

Market Cap Rank

#14061 Global

#4122 in China

Share Price

CN¥3.84

Change (1 day)

-0.52%

52-Week Range

CN¥2.61 - CN¥5.70

All Time High

CN¥24.91